B7-H3 expression associates with tumor invasion and patient's poor survival in human esophageal cancer.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 26885263)

Published in Am J Transl Res on December 15, 2015

Authors

Lujun Chen1, Jun Chen2, Bin Xu1, Qi Wang1, Wei Zhou3, Guangbo Zhang4, Jing Sun4, Liangrong Shi1, Honglei Pei2, Changping Wu1, Jingting Jiang1

Author Affiliations

1: Department of Tumor Biological TreatmentChangzhou 213003, Jiangsu, China; Jiangsu Engineering Research Center for Tumor ImmunotherapyChangzhou 213003, Jiangsu, China.
2: Department of Radiation Oncology, Third Affiliated Hospital of Soochow University Changzhou 213003, China.
3: Department of Cell Biology, School of Medicine, Soochow University Suzhou 215123, Jiangsu, China.
4: Department of Clinical Immunology, First Affiliated Hospital of Soochow University Suzhou, China.

Articles cited by this

Global cancer statistics. CA Cancer J Clin (2011) 185.92

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med (2012) 52.99

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science (2006) 24.54

Esophageal cancer. N Engl J Med (2003) 15.23

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients. Nature (2014) 12.00

PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature (2014) 10.39

Inhibitory B7-family molecules in the tumour microenvironment. Nat Rev Immunol (2008) 8.17

The B7-CD28 superfamily. Nat Rev Immunol (2002) 7.24

B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat Immunol (2001) 4.10

Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance. Acta Histochem (2006) 3.24

Research on esophageal cancer in China: a review. Cancer Res (1980) 3.17

High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J Clin Oncol (2008) 2.92

B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome. Proc Natl Acad Sci U S A (2007) 2.37

Etiology and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis (2001) 2.27

Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains. J Immunol (2004) 2.23

B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy. Cancer Res (2007) 2.19

Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma. Clin Cancer Res (2008) 1.97

Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses. Proc Natl Acad Sci U S A (2008) 1.77

B7-H3 over expression in prostate cancer promotes tumor cell progression. J Urol (2011) 1.71

Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas. Mod Pathol (2010) 1.44

B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma. Cancer Immunol Immunother (2011) 1.34

Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma. Cancer Immunol Immunother (2010) 1.28

T-cell-mediated tumor immune surveillance and expression of B7 co-inhibitory molecules in cancers of the upper gastrointestinal tract. Immunol Res (2011) 1.21

The expression, function, and clinical relevance of B7 family members in cancer. Cancer Immunol Immunother (2012) 1.20

B7-h3 and its role in antitumor immunity. Clin Dev Immunol (2010) 1.14

Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance. Int J Clin Oncol (2014) 1.13

Immunochemical staining of MT2-MMP correlates positively to angiogenesis of human esophageal cancer. Anticancer Res (2010) 1.12

B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes. Int J Cancer (2011) 1.12

Epidemiology of cancer of the esophagus. Semin Oncol (1984) 1.09

Higher numbers of T-bet(+) intratumoral lymphoid cells correlate with better survival in gastric cancer. Cancer Immunol Immunother (2012) 1.05

Chemoprevention of esophageal squamous cell carcinoma. Toxicol Appl Pharmacol (2007) 1.04

B7-H3 overexpression in pancreatic cancer promotes tumor progression. Int J Mol Med (2012) 1.02

B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence. Cancer Immunol Immunother (2012) 1.00

Expression of B7-H3 in hypopharyngeal squamous cell carcinoma as a predictive indicator for tumor metastasis and prognosis. Int J Oncol (2011) 0.97

Immunolocalisation of tissue factor in esophageal cancer is correlated with intratumoral angiogenesis and prognosis of the patient. Acta Histochem (2009) 0.90

B7-H3 was highly expressed in human primary hepatocellular carcinoma and promoted tumor progression. Cancer Invest (2014) 0.82